InsidersTradesSigma
Explore the complete record of transactions filed by Kelly Paul Edward, Director. Insider active across 1 companies, notably Relmada Therapeutics, INC.. In total, 3 filings have been published. The latest transaction was disclosed on 4 April 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations
Paul Edward Kelly is a Board Member of Relmada Therapeutics, Inc., a biotechnology company. As a board member, he participates in overseeing the company's activities and making strategic decisions. His expertise in the biotechnology field is valuable for guiding Relmada's initiatives.